Active Purchasing: Empirical Insights From the Dutch Healthcare System and Lessons for Low- and Middle-Income Countries; Comment on “Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands”

Document Type : Commentary

Authors

1 Health, Nutrition, and Population Global Practice, World Bank Group, Washington, DC, USA

2 Department of Global Health, School of Public Health, University of Washington, Seattle, WA, USA

3 Evans School of Public Policy and Governance, University of Washington, Seattle, WA, USA

Abstract

Stadhouders et al critically examines the assumptions behind managed competition, revealing that competitive systems alone may not drive efficiency gains through fund reallocation. Their findings from the Dutch hospital sector suggest limited or low reallocation of funds between providers and highlight the need for monitoring resource allocation progress, understanding barriers and adjusting incentives for better functioning healthcare markets. For low- and middle-income countries (LMICs) undergoing health reforms, the Dutch experience underscores the importance of tailoring purchasing models to local contexts. LMICs should enhance data use for more strategic decision-making as well as building regulatory framework and institutional capacity for stronger implementation. Future research should explore how purchasing models interact with diverse health system characteristics to inform system-specific reforms. 

Keywords


  1. Stadhouders NW, Koolman X, Tanke MAC, Maarse H, Jeurissen PPT. Measuring active purchasing in healthcare: analysing reallocations of funds between providers to evaluate purchasing systems performance in the Netherlands. Int J Health Policy Manag. 2023;12:7506. doi:34172/ijhpm.2023.7506
  2. Dohmen P, van Ineveld M, Markus A, van der Hagen L, van de Klundert J. Does competition improve hospital performance: a DEA based evaluation from the Netherlands. Eur J Health Econ. 2023;24(6):999-1017. doi:1007/s10198-022-01529-8
  3. Langenbrunner JC, Hovig D, Cashin C. Trends in health financing: the move from passive to strategic purchasing in middle- and low-income countries. World Hosp Health Serv. 2016;52(4):12-19.
  4. Figueras J, Robinson R, Jakubowski E. Purchasing to Improve Health Systems Performance. Maidenhead: Open University Press; 2005.
  5. Amporfu E, Agyei-Baffour P, Edusei A, Novignon J, Arthur E. Strategic health purchasing progress mapping: a spotlight on Ghana's National Health Insurance Scheme. Health Syst Reform. 2022;8(2):e2058337. doi:1080/23288604.2022.2058337
  6. Tangcharoensathien V, Limwattananon S, Patcharanarumol W, Thammatacharee J, Jongudomsuk P, Sirilak S. Achieving universal health coverage goals in Thailand: the vital role of strategic purchasing. Health Policy Plan. 2015;30(9):1152-1161. doi:1093/heapol/czu120
  7. Kabia E, Kazungu J, Barasa E. The effects of health purchasing reforms on equity, access, quality of care, and financial protection in Kenya: a narrative review. Health Syst Reform. 2022;8(2):2114173. doi:1080/23288604.2022.2114173
  8. Kutzin J, Yip W, Cashin C. Alternative financing strategies for universal health coverage. In: World Scientific Handbook of Global Health Economics and Public Policy. World Scientific; 2016:267-309. doi:1142/9789813140493_0005
  9. Skiles MP, Curtis SL, Basinga P, Angeles G, Thirumurthy H. The effect of performance-based financing on illness, care-seeking and treatment among children: an impact evaluation in Rwanda. BMC Health Serv Res. 2015;15:375. doi:1186/s12913-015-1033-7

Articles in Press, Corrected Proof
Available Online from 12 July 2025
  • Received Date: 18 April 2025
  • Revised Date: 18 June 2025
  • Accepted Date: 09 July 2025
  • First Published Date: 12 July 2025